These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 973177)

  • 1. [Long-term clinical-dispensary treatment of patients with systemic scleroderma].
    Grinberg NB; Ivanova AV
    Ter Arkh; 1976; 48(6):115-9. PubMed ID: 973177
    [No Abstract]   [Full Text] [Related]  

  • 2. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.
    Hoyles RK; Ellis RW; Wellsbury J; Lees B; Newlands P; Goh NS; Roberts C; Desai S; Herrick AL; McHugh NJ; Foley NM; Pearson SB; Emery P; Veale DJ; Denton CP; Wells AU; Black CM; du Bois RM
    Arthritis Rheum; 2006 Dec; 54(12):3962-70. PubMed ID: 17133610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of systemic lupus erythematosus and systemic scleroderma with heparin].
    Gorbunova ZV; Iakimova NIa; Sukhanov AA; Grinberg NB
    Klin Med (Mosk); 1974; 52(8):55-8. PubMed ID: 4418071
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effectiveness of long-term use of dimethyl sulfoxide in the complex treatment of patients with systemic scleroderma].
    Murav'ev IuV; Aliab'eva AP; Sigidin IaA; Guseva NG; Balabanova RM
    Ter Arkh; 1985; 57(8):125-7. PubMed ID: 3906994
    [No Abstract]   [Full Text] [Related]  

  • 5. Persistence of abnormal bronchoalveolar lavage findings after cyclophosphamide treatment in scleroderma patients with interstitial lung disease.
    Mittoo S; Wigley FM; Wise R; Xiao H; Hummers L
    Arthritis Rheum; 2007 Dec; 56(12):4195-202. PubMed ID: 18050251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of diffuse scleroderma with heparin].
    Michałowski R; Kozak S
    Przegl Dermatol; 1976; (6 Suppl):363-6. PubMed ID: 1032187
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immediate results of long-term treatment of systemic scleroderma with leukeran].
    Olszewska Z
    Reumatologia; 1978; 16(2):259-66. PubMed ID: 358343
    [No Abstract]   [Full Text] [Related]  

  • 8. [Heparin in diffuse scleroderma (author's transl)].
    Michałowski R; Kozak S
    Dermatol Monatsschr; 1979 Dec; 165(12):833-7. PubMed ID: 397907
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of oral cyclophosphamide and prednisolone therapy on the endothelial functions and clinical findings in patients with early diffuse systemic sclerosis.
    Apras S; Ertenli I; Ozbalkan Z; Kiraz S; Ozturk MA; Haznedaroglu IC; Cobankara V; Pay S; Calguneri M
    Arthritis Rheum; 2003 Aug; 48(8):2256-61. PubMed ID: 12905480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of oral cyclophosphamide plus prednisolone in early diffuse systemic sclerosis.
    Calguneri M; Apras S; Ozbalkan Z; Ertenli I; Kiraz S; Ozturk MA; Celik I
    Clin Rheumatol; 2003 Oct; 22(4-5):289-94. PubMed ID: 14579158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Albumin metabolism in patients with chronic glomerulonephritis in relation to various types of treatment].
    Chan RB
    Urol Nefrol (Mosk); 1987; (3):46-50. PubMed ID: 3617283
    [No Abstract]   [Full Text] [Related]  

  • 12. [Long-term, small-dose cyclophosphamide treatment of severe inflammatory joint diseases].
    Chaouat Y; Paquet J; Pélisson J; Kanovitch B; Rascovscki S
    Rev Rhum Mal Osteoartic; 1968 Dec; 35(12):649-56. PubMed ID: 5717215
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of scleroderma with dimethylsulfoxide].
    Serggev VP; Zakiev RZ
    Vestn Dermatol Venerol; 1976 Mar; (3):70-3. PubMed ID: 961055
    [No Abstract]   [Full Text] [Related]  

  • 14. [Piascledine in the treatment of scleroderma].
    Szczepański A; Dabrowska H; Moskalewska K
    Przegl Dermatol; 1974; 61(4):525-7. PubMed ID: 4849404
    [No Abstract]   [Full Text] [Related]  

  • 15. [Generalized scleroderma. Treatment with immunosuppressive agents].
    Saporta L; Godeau P; Delrieu F; Delbarre F
    Nouv Presse Med; 1972 Jul; 1(29):1929-30. PubMed ID: 5053601
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapeutic effectiveness of ultrasonics and lidase phonophoresis in various forms of scleroderma].
    Didenko IG
    Vestn Dermatol Venerol; 1978 Jun; (6):76-9. PubMed ID: 354249
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study.
    Khanna D; Yan X; Tashkin DP; Furst DE; Elashoff R; Roth MD; Silver R; Strange C; Bolster M; Seibold JR; Riley DJ; Hsu VM; Varga J; Schraufnagel DE; Theodore A; Simms R; Wise R; Wigley F; White B; Steen V; Read C; Mayes M; Parsley E; Mubarak K; Connolly MK; Golden J; Olman M; Fessler B; Rothfield N; Metersky M; Clements PJ;
    Arthritis Rheum; 2007 May; 56(5):1676-84. PubMed ID: 17469162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclophosphamide therapy for scleroderma.
    Akesson A
    Curr Opin Rheumatol; 1998 Nov; 10(6):579-83. PubMed ID: 9812219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease.
    Silver RM; Warrick JH; Kinsella MB; Staudt LS; Baumann MH; Strange C
    J Rheumatol; 1993 May; 20(5):838-44. PubMed ID: 8336309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies in 25 patients with progressive systemic scleroderma treated by long-term administration of griseofulvin].
    Giordano M; Ara M; Capelli L; Tirri G; Pettinato G; Vatti M
    Minerva Med; 1973 Jun; 64(46):2451-66. PubMed ID: 4579328
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.